Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Cash & Current Investments: 2011-2025

Historic Cash & Current Investments for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to $142.1 million.

  • Mimedx Group's Cash & Current Investments rose 60.00% to $142.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $471.8 million, marking a year-over-year increase of 63.63%. This contributed to the annual value of $104.4 million for FY2024, which is 27.34% up from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's Cash & Current Investments is $142.1 million, which was up 19.53% from $118.9 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Cash & Current Investments peaked at $142.1 million during Q3 2025, and registered a low of $48.5 million during Q1 2024.
  • Over the past 3 years, Mimedx Group's median Cash & Current Investments value was $85.4 million (recorded in 2023), while the average stood at $89.0 million.
  • In the last 5 years, Mimedx Group's Cash & Current Investments decreased by 24.27% in 2022 and then spiked by 119.50% in 2025.
  • Mimedx Group's Cash & Current Investments (Quarterly) stood at $87.1 million in 2021, then fell by 24.27% to $66.0 million in 2022, then climbed by 24.34% to $82.0 million in 2023, then rose by 27.34% to $104.4 million in 2024, then spiked by 60.00% to $142.1 million in 2025.
  • Its last three reported values are $142.1 million in Q3 2025, $118.9 million for Q2 2025, and $106.4 million during Q1 2025.